DC Field | Value | Language |
dc.contributor.author | Șcarăbnîi, Ruslan | |
dc.contributor.author | Vatamaniuc, Mihaela | |
dc.date.accessioned | 2021-11-10T14:38:40Z | |
dc.date.available | 2021-11-10T14:38:40Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | ȘCARĂBNÎI, Ruslan, VATAMANIUC, Mihaela. The experience of treatment with isotrexin gel in acne vulgaris. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, pp. 100-101. | en_US |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/18442 | |
dc.description | Department Dermatovenereology, Republic of Moldova. | en_US |
dc.description.abstract | Introduction: Isotretinoin (13-cis-retinoic acid) is a derivative of vitamin A, being a
stereoisomer of tretinoin. Applied topically it has the following actions:1. Regulates the
keratinization, reducing the cohesion between the keratinocytes at the level of pilo-sebaceous
infundibulum and stratum corneum, promoting and preventing peeling and the appearance of
comedones; 2. Determines decrease by 50% of sebaceous gland size; 3. Inhibits the migration of
polymorphonuclear neutrophils induced by leukotriene B4, thus having anti-inflammatory action.
Purpose and objectives: The efficacy and safety of treatment with gel Istorexin in acne
vulgaris Il-nd and Ill-rd degree.
Materials and methods: For observations were subjected 30 patients with acne vulgaris Il-nd
and Ill-rd degree (12 men and 18 women, mean age 20 ± 4 years). Inclusion criteria according to the
degree of acne severity proposed by G.Plewig,M.Kligman,.2004: 20 patients with acne vulgaris, Il-nd
degree: more than 20 comedones, 10-20 papulopustular units; 10 patients with acne vulgaris, Ill-rd
gedree: huge number of comedones, over 21 to 30 papulopustular units , up to 5 nodules.The algorithm
of implementation: 1) thorough cleansing of the skin with prior degresation;2) Istorexin gel, 2 times
daily, on the affected areas (eight weeks); 3) Cream complementary for excessive dryness of skin.
The drug is not applied on skin with other solutions or other dermatoses (eczema, irritant
contact dermatitis, excoriation...). The evidence of morphological features in the focal lesion is
made before the begining of the treatment and during the therapy over 1 to 2 months.
Results: At the end of the observation period (8 weeks) was noticed: reduction in open and closed
comedones - in the average o f 28 ± 1 to 9± 1, reduction of bullous - papulopustular eruptions - from 20
± 1 to 7 ± 1; skin lesions during the conduct of the therapy becomes smooth and elastic. Endpoint (8
weeks): clinical recovery - 15 patients (50%), significant improvement - 8 patients (25%), the total
clinical score (recovery + improvement) - 75%. Safety Results Notes: 5 patients (16%) reported a
significant subjective sensations of dry skin tension on the face, the indication of moisturizing cosmetic
preparations allowed coupling of this state during the 4-5 days without suspension of the gel, this way
Istorexin gel was maximal efficient and not led to cases of suspension of the treatment.
Conclusions: The combined topic acne efficacy profile showed a high efficacy (75%) and a
maximal safety (in combination with other moisturizing cosmetic drugs) in the treatment of patients
with medium and severe forms of acne vulgaris, Il-nd and Ill-rd degree. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association | en_US |
dc.relation.ispartof | MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova | en_US |
dc.subject | Acne vulgaris | en_US |
dc.subject | isotrexin gel | en_US |
dc.title | The experience of treatment with isotrexin gel in acne vulgaris | en_US |
dc.type | Other | en_US |
Appears in Collections: | MedEspera 2014
|